$CTMX
CytomX Therapeutics, Inc.
XNAS•Health Care•Pharmaceutical Preparations
$2.69
▲+2.16%+$0.057
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateCytomX Therapeutics, Inc.
XNAS•Health Care•Pharmaceutical Preparations
Why is CTMX up today? It is at $2.69 (+2.16%), and our scanner flagged it 85 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CTMX spikes, and full due diligence on CTMX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $CTMX 85 times in the last 30 days. Create a free account to track $CTMX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on CTMX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CTMX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Carvajal Alejandra Officer | Acquired (grant/award) | +100K 0.05% of company | n/a | 100K | n/a | Aug 3, 26 |
Ogden Christopher Officer | Sold (automatic/other) | -2K | sold 0.5% | 295K | $5K at $3.05 | Jun 15, 26 |
Ogden Christopher Officer | Sold (automatic/other) | -19K | sold 6.1% | 297K | $124K at $6.42 | Mar 17, 26 |
Belvin Marcia Officer | Sold (automatic/other) | -31K 0.01% of company | sold 9.5% | 301K | $202K at $6.42 | Mar 17, 26 |
Mccarthy Sean A. Officer | Sold (automatic/other) | -119K 0.05% of company | sold 9.9% | 1.08M | $764K at $6.42 | Mar 17, 26 |
Chu Yu-Waye Officer | Sold (automatic/other) | -21K | sold 10% | 189K | $137K at $6.42 | Mar 17, 26 |
Mccarthy Sean A. Officer | Acquired (grant/award) | +210K 0.10% of company | added 21% | 1.20M | n/a | Feb 2, 26 |
Ogden Christopher Officer | Acquired (grant/award) | +90K 0.04% of company | added 40% | 316K | n/a | Feb 2, 26 |
Belvin Marcia Officer | Acquired (grant/award) | +60K 0.03% of company | added 22% | 332K | n/a | Feb 2, 26 |
Chu Yu-Waye Officer | Acquired (grant/award) | +75K 0.03% of company | added 55% | 211K | n/a | Feb 2, 26 |
Lester Rachael Officer | Acquired (grant/award) | +20K | n/a | 20K | n/a | Feb 2, 26 |
Mccarthy Sean A. Officer | Sold (automatic/other) | -102K 0.05% of company | sold 9.3% | 988K | $462K at $4.54 | Nov 6, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on CTMX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CTMX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
CTMX last traded at $2.69, up 2.16% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
CytomX Therapeutics, Inc. (CTMX) is next expected to report earnings on Thursday, November 5, 2026, about 32 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The CTMX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CTMX 85 times in the last 30 days.
CTMX (CytomX Therapeutics, Inc.) trades on XNAS, with a market cap of about $558M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CTMX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$CTMX discussion
Sign in to ask a question or join the discussion.